Atom | Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Due Dates: April 4, 2025 | October 3, 2025 | December 9, 2025 (final closing date)

Funding Amounts: Up to $300,000 per year (direct costs), max 3 years; total program funding $300,000; ~2 awards expected.

Summary: Supports advanced development and validation of emerging biospecimen science technologies to improve sample quality and handling for cancer research or care.

Key Information: Clinical trials are not allowed; projects must focus on technology development/validation, not hypothesis-driven research.

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Sign in to see full grant listing